{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T19:33:08Z","timestamp":1786995188815,"version":"build-2736575974"},"reference-count":85,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,5,3]],"date-time":"2024-05-03T00:00:00Z","timestamp":1714694400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"NIH","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular Therapy - Nucleic Acids"],"published-print":{"date-parts":[[2024,6]]},"DOI":"10.1016\/j.omtn.2024.102211","type":"journal-article","created":{"date-parts":[[2024,5,7]],"date-time":"2024-05-07T12:37:42Z","timestamp":1715085462000},"page":"102211","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"title":["Adeno-associated virus-based gene therapy delivering combinations of two growth-associated genes to MPS IVA mice"],"prefix":"10.1016","volume":"35","author":[{"given":"Estera","family":"Rintz","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Betul","family":"Celik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nidhi","family":"Fnu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ang\u00e9lica Mar\u00eda","family":"Herre\u00f1o-Pach\u00f3n","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shaukat","family":"Khan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eliana","family":"Benincore-Fl\u00f3rez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0673-2160","authenticated-orcid":false,"given":"Shunji","family":"Tomatsu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.omtn.2024.102211_bib1","doi-asserted-by":"crossref","first-page":"273","DOI":"10.3390\/diagnostics11020273","article-title":"Epidemiology of Mucopolysaccharidoses Update","volume":"11","author":"\u00c7elik","year":"2021","journal-title":"Diagnostics"},{"key":"10.1016\/j.omtn.2024.102211_bib2","doi-asserted-by":"crossref","first-page":"172","DOI":"10.3390\/diagnostics10030172","article-title":"Diagnosis of Mucopolysaccharidoses","volume":"10","author":"Kubaski","year":"2020","journal-title":"Diagnostics"},{"key":"10.1016\/j.omtn.2024.102211_bib3","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1590\/S1415-47572012000600006","article-title":"Mucopolysacccharidoses: From understanding to treatment., a century of discoveries","volume":"35","author":"Giugliani","year":"2012","journal-title":"Genet. Mol. Biol."},{"key":"10.1016\/j.omtn.2024.102211_bib4","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1136\/jmedgenet-2021-108061","article-title":"Novel subtype of mucopolysaccharidosis caused by arylsulfatase K (ARSK) deficiency","volume":"59","author":"Verheyen","year":"2022","journal-title":"J.\u00a0Med. Genet."},{"key":"10.1016\/j.omtn.2024.102211_bib5","doi-asserted-by":"crossref","first-page":"2249","DOI":"10.4103\/ijo.IJO_425_22","article-title":"Mucopolysaccharidosis: A broad review","volume":"70","author":"Nagpal","year":"2022","journal-title":"Indian J. Ophthalmol."},{"key":"10.1016\/j.omtn.2024.102211_bib6","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejphar.2020.173534","article-title":"Has resveratrol a potential for mucopolysaccharidosis treatment?","volume":"888","author":"Rintz","year":"2020","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.omtn.2024.102211_bib7","doi-asserted-by":"crossref","DOI":"10.1155\/2020\/2408402","article-title":"Mucopolysaccharidoses I and II: Brief Review of Therapeutic Options and Supportive\/Palliative Therapies","volume":"2020","author":"Nan","year":"2020","journal-title":"BioMed Res. Int."},{"key":"10.1016\/j.omtn.2024.102211_bib8","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/j.ymgme.2018.01.003","article-title":"Clinical presentation and diagnosis of mucopolysaccharidoses","volume":"125","author":"Stapleton","year":"2018","journal-title":"Mol. Genet. Metabol."},{"key":"10.1016\/j.omtn.2024.102211_bib9","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1186\/s12987-020-00209-0","article-title":"Differential expression of receptors mediating receptor-mediated transcytosis (RMT) in brain microvessels., brain parenchyma and peripheral tissues of the mouse and the human","volume":"17","author":"Zhang","year":"2020","journal-title":"Fluids Barriers CNS"},{"key":"10.1016\/j.omtn.2024.102211_bib10","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.ymgme.2017.12.434","article-title":"Gene therapy for Mucopolysaccharidoses","volume":"123","author":"Sawamoto","year":"2018","journal-title":"Mol. Genet. Metabol."},{"key":"10.1016\/j.omtn.2024.102211_bib11","doi-asserted-by":"crossref","DOI":"10.1038\/srep14144","article-title":"RTB Lectin: a novel receptor-independent delivery system for lysosomal enzyme replacement therapies","volume":"5","author":"Acosta","year":"2015","journal-title":"Sci. Rep."},{"key":"10.1016\/j.omtn.2024.102211_bib12","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1002\/bit.21602","article-title":"Genetic engineering of a lysosomal enzyme fusion protein for targeted delivery across the human blood-brain barrier","volume":"99","author":"Boado","year":"2008","journal-title":"Biotechnol. Bioeng."},{"key":"10.1016\/j.omtn.2024.102211_bib13","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1016\/j.omtm.2023.05.010","article-title":"Enzyme replacement with transferrin receptor-targeted \u03b1-L-iduronidase rescues brain pathology in mucopolysaccharidosis I mice","volume":"29","author":"Kida","year":"2023","journal-title":"Mol. Ther. Methods Clin. Dev."},{"key":"10.1016\/j.omtn.2024.102211_bib14","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1021\/bc900382q","article-title":"Genetic engineering of a bifunctional IgG fusion protein with iduronate-2-sulfatase","volume":"21","author":"Lu","year":"2010","journal-title":"Bioconjugate Chem."},{"key":"10.1016\/j.omtn.2024.102211_bib15","doi-asserted-by":"crossref","first-page":"1366","DOI":"10.1016\/j.ymthe.2018.02.032","article-title":"A Blood-Brain-Barrier-Penetrating Anti-human Transferrin Receptor Antibody Fusion Protein for Neuronopathic Mucopolysaccharidosis II","volume":"26","author":"Sonoda","year":"2018","journal-title":"Mol. Ther."},{"key":"10.1016\/j.omtn.2024.102211_bib16","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1042\/BJ20130845","article-title":"Insulin-like growth factor II peptide fusion enables uptake and lysosomal delivery of \u03b1-N-acetylglucosaminidase to mucopolysaccharidosis type IIIB fibroblasts","volume":"458","author":"Kan","year":"2014","journal-title":"Biochem. J."},{"key":"10.1016\/j.omtn.2024.102211_bib17","doi-asserted-by":"crossref","first-page":"1385","DOI":"10.1021\/acs.molpharmaceut.6b00037","article-title":"Insulin Receptor Antibody-\u03b1-N-Acetylglucosaminidase Fusion Protein Penetrates the Primate Blood-Brain Barrier and Reduces Glycosoaminoglycans in Sanfilippo Type B Fibroblasts","volume":"13","author":"Boado","year":"2016","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.omtn.2024.102211_bib18","doi-asserted-by":"crossref","first-page":"205","DOI":"10.3109\/10611860903353362","article-title":"Genetic engineering of IgG-glucuronidase fusion proteins","volume":"18","author":"Boado","year":"2010","journal-title":"J.\u00a0Drug Target."},{"key":"10.1016\/j.omtn.2024.102211_bib19","doi-asserted-by":"crossref","first-page":"477","DOI":"10.3390\/ijms24010477","article-title":"Mucopolysaccharidoses: Cellular Consequences of Glycosaminoglycans Accumulation and Potential Targets","volume":"24","author":"Leal","year":"2022","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.omtn.2024.102211_bib20","doi-asserted-by":"crossref","first-page":"189","DOI":"10.3390\/biom11020189","article-title":"Mucopolysaccharidosis Type I: Current Treatments., Limitations., and Prospects for Improvement","volume":"11","author":"Hampe","year":"2021","journal-title":"Biomolecules"},{"key":"10.1016\/j.omtn.2024.102211_bib21","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1186\/s13023-016-0470-7","article-title":"Musculoskeletal manifestations in mucopolysaccharidosis type I (Hurler syndrome) following hematopoietic stem cell transplantation","volume":"11","author":"Schmidt","year":"2016","journal-title":"Orphanet J. Rare Dis."},{"key":"10.1016\/j.omtn.2024.102211_bib22","doi-asserted-by":"crossref","first-page":"1517","DOI":"10.3390\/ijms21041517","article-title":"Mucopolysaccharidosis IVA: Diagnosis., Treatment., and Management","volume":"21","author":"Sawamoto","year":"2020","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.omtn.2024.102211_bib23","doi-asserted-by":"crossref","first-page":"1466","DOI":"10.1089\/scd.2011.0555","article-title":"Hurler disease bone marrow stromal cells exhibit altered ability to support osteoclast formation","volume":"21","author":"Gatto","year":"2012","journal-title":"Stem Cell. Dev."},{"key":"10.1016\/j.omtn.2024.102211_bib24","first-page":"13","article-title":"Bone density assessment in patients with mucopolysaccharidosis: A preliminary report from patients with MPS II and VI","volume":"3","author":"Fung","year":"2010","journal-title":"J.\u00a0Pediatr. Rehabil. Med."},{"key":"10.1016\/j.omtn.2024.102211_bib25","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1007\/s00774-016-0762-y","article-title":"Bone mineral density in patients with mucopolysaccharidosis type III","volume":"35","author":"Nur","year":"2017","journal-title":"J.\u00a0Bone Miner. Metabol."},{"key":"10.1016\/j.omtn.2024.102211_bib26","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/j.ymgme.2016.11.007","article-title":"Mucopolysaccharidosis IVA and glycosaminoglycans","volume":"120","author":"Khan","year":"2017","journal-title":"Mol. Genet. Metabol."},{"key":"10.1016\/j.omtn.2024.102211_bib27","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1016\/j.ymthe.2003.12.009","article-title":"Gene therapy platform for bone regeneration using an exogenously regulated, AAV-2-based gene expression system","volume":"9","author":"Gafni","year":"2004","journal-title":"Mol. Ther."},{"key":"10.1016\/j.omtn.2024.102211_bib28","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1601-6343.2007.00381.x","article-title":"The use of recombinant adeno-associated virus for skeletal gene therapy","volume":"10","author":"Dai","year":"2007","journal-title":"Orthod. Craniofac. Res."},{"key":"10.1016\/j.omtn.2024.102211_bib29","doi-asserted-by":"crossref","first-page":"922","DOI":"10.1016\/j.omtm.2020.04.010","article-title":"Bone-Targeting AAV-Mediated Gene Silencing in Osteoclasts for Osteoporosis Therapy","volume":"17","author":"Yang","year":"2020","journal-title":"Mol. Ther. Methods Clin. Dev."},{"key":"10.1016\/j.omtn.2024.102211_bib30","doi-asserted-by":"crossref","DOI":"10.1016\/j.omtn.2023.102111","article-title":"AAV-based gene editing of type 1 collagen mutation to treat osteogenesis imperfecta","volume":"35","author":"Yang","year":"2024","journal-title":"Mol. Ther. Nucleic Acids"},{"key":"10.1016\/j.omtn.2024.102211_bib31","doi-asserted-by":"crossref","DOI":"10.3390\/ijms232012693","article-title":"Sex Difference Leads to Differential Gene Expression Patterns and Therapeutic Efficacy in Mucopolysaccharidosis IVA Murine Model Receiving AAV8 Gene Therapy","volume":"23","author":"Piechnik","year":"2022","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.omtn.2024.102211_bib32","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.omtm.2020.05.015","article-title":"Liver-Targeted AAV8 Gene Therapy Ameliorates Skeletal and Cardiovascular Pathology in a Mucopolysaccharidosis IVA Murine Model","volume":"18","author":"Sawamoto","year":"2020","journal-title":"Mol. Ther. Methods Clin. Dev."},{"key":"10.1016\/j.omtn.2024.102211_bib33","doi-asserted-by":"crossref","first-page":"9890","DOI":"10.3390\/ijms24129890","article-title":"Bone Growth Induction in Mucopolysaccharidosis IVA Mouse","volume":"24","author":"Rintz","year":"2023","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.omtn.2024.102211_bib34","doi-asserted-by":"crossref","DOI":"10.1016\/j.omtn.2023.102057","article-title":"Efficacy and safety of a SOD1-targeting artificial miRNA delivered by AAV9 in mice are impacted by miRNA scaffold selection","volume":"34","author":"Chen","year":"2023","journal-title":"Mol. Ther. Nucleic Acids"},{"key":"10.1016\/j.omtn.2024.102211_bib35","doi-asserted-by":"crossref","first-page":"1042","DOI":"10.1038\/mt.2016.61","article-title":"Superior In\u00a0vivo Transduction of Human Hepatocytes Using Engineered AAV3 Capsid","volume":"24","author":"Vercauteren","year":"2016","journal-title":"Mol. Ther."},{"key":"10.1016\/j.omtn.2024.102211_bib36","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.ymthe.2006.03.014","article-title":"Robust systemic transduction with AAV9 vectors in mice: efficient global cardiac gene transfer superior to that of AAV8","volume":"14","author":"Inagaki","year":"2006","journal-title":"Mol. Ther."},{"key":"10.1016\/j.omtn.2024.102211_bib37","doi-asserted-by":"crossref","first-page":"785","DOI":"10.3390\/cells12050785","article-title":"Various AAV Serotypes and Their Applications in Gene Therapy: An Overview","volume":"12","author":"Issa","year":"2023","journal-title":"Cells"},{"key":"10.1016\/j.omtn.2024.102211_bib38","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1016\/j.omtn.2023.02.011","article-title":"In\u00a0vivo base editing rescues photoreceptors in a mouse model of retinitis pigmentosa","volume":"31","author":"Su","year":"2023","journal-title":"Mol. Ther. Nucleic Acids"},{"key":"10.1016\/j.omtn.2024.102211_bib39","doi-asserted-by":"crossref","first-page":"1559","DOI":"10.1089\/hum.2019.127","article-title":"Comparison of Gene Delivery to the Kidney by Adenovirus, Adeno-Associated Virus, and Lentiviral Vectors After Intravenous and Direct Kidney Injections","volume":"30","author":"Rubin","year":"2019","journal-title":"Hum. Gene Ther."},{"key":"10.1016\/j.omtn.2024.102211_bib40","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1089\/104303404322959551","article-title":"Comparison of adenoviral and adeno-associated viral vectors for pancreatic gene delivery in\u00a0vivo","volume":"15","author":"Wang","year":"2004","journal-title":"Hum. Gene Ther."},{"key":"10.1016\/j.omtn.2024.102211_bib41","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1038\/mt.2008.76","article-title":"Analysis of AAV serotypes 1-9 mediated gene expression and tropism in mice after systemic injection","volume":"16","author":"Zincarelli","year":"2008","journal-title":"Mol. Ther."},{"key":"10.1016\/j.omtn.2024.102211_bib42","doi-asserted-by":"crossref","first-page":"12260","DOI":"10.1128\/JVI.01304-07","article-title":"Structure of adeno-associated virus serotype 8, a gene therapy vector","volume":"81","author":"Nam","year":"2007","journal-title":"J.\u00a0Virol."},{"key":"10.1016\/j.omtn.2024.102211_bib43","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1128\/JVI.79.1.214-224.2005","article-title":"Unrestricted hepatocyte transduction with adeno-associated virus serotype 8 vectors in mice","volume":"79","author":"Nakai","year":"2005","journal-title":"J.\u00a0Virol."},{"key":"10.1016\/j.omtn.2024.102211_bib44","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1093\/hmg\/ddm353","article-title":"Enzyme replacement therapy in a murine model of Morquio A syndrome","volume":"17","author":"Tomatsu","year":"2008","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.omtn.2024.102211_bib45","doi-asserted-by":"crossref","first-page":"3349","DOI":"10.1093\/hmg\/ddg366","article-title":"Mouse model of N-acetylgalactosamine-6-sulfate sulfatase deficiency (Galns-\/-) produced by targeted disruption of the gene defective in Morquio A disease","volume":"12","author":"Tomatsu","year":"2003","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.omtn.2024.102211_bib46","doi-asserted-by":"crossref","first-page":"1094","DOI":"10.1038\/mt.2010.32","article-title":"Enhancement of drug delivery: enzyme-replacement therapy for murine Morquio A syndrome","volume":"18","author":"Tomatsu","year":"2010","journal-title":"Mol. Ther."},{"key":"10.1016\/j.omtn.2024.102211_bib47","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/j.ymgme.2014.05.013","article-title":"Enzyme replacement therapy in newborn mucopolysaccharidosis IVA mice: early treatment rescues bone lesions?","volume":"114","author":"Tomatsu","year":"2015","journal-title":"Mol. Genet. Metabol."},{"key":"10.1016\/j.omtn.2024.102211_bib48","doi-asserted-by":"crossref","first-page":"1202","DOI":"10.1007\/s00247-020-04946-0","article-title":"Tracheal narrowing in children and adults with mucopolysaccharidosis type IVA: evaluation with computed tomography angiography","volume":"51","author":"Averill","year":"2021","journal-title":"Pediatr. Radiol."},{"key":"10.1016\/j.omtn.2024.102211_bib49","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.ymgmr.2017.11.005","article-title":"Natural history of Morquio A patient with tracheal obstruction from birth to death","volume":"14","author":"Doherty","year":"2018","journal-title":"Mol. Genet. Metab. Rep."},{"key":"10.1016\/j.omtn.2024.102211_bib50","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1016\/j.ymgme.2015.09.007","article-title":"Obstructive airway in Morquio A syndrome., the past., the present and the future","volume":"117","author":"Tomatsu","year":"2016","journal-title":"Mol. Genet. Metabol."},{"key":"10.1016\/j.omtn.2024.102211_bib51","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1186\/s13023-021-01675-x","article-title":"Impact of long-term elosulfase alfa treatment on clinical and patient-reported outcomes in patients with mucopolysaccharidosis type IVA: results from a Managed Access Agreement in England","volume":"16","author":"Cleary","year":"2021","journal-title":"Orphanet J. Rare Dis."},{"key":"10.1016\/j.omtn.2024.102211_bib52","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1038\/s10038-019-0604-6","article-title":"Effect of enzyme replacement therapy on the growth of patients with Morquio A","volume":"64","author":"Doherty","year":"2019","journal-title":"J.\u00a0Hum. Genet."},{"key":"10.1016\/j.omtn.2024.102211_bib53","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1186\/s13023-018-0883-6","article-title":"Cardiac features and effects of enzyme replacement therapy in Taiwanese patients with Mucopolysaccharidosis IVA","volume":"13","author":"Lin","year":"2018","journal-title":"Orphanet J. Rare Dis."},{"key":"10.1016\/j.omtn.2024.102211_bib54","article-title":"Biomarkers in patients with mucopolysaccharidosis type II and IV","volume":"19","author":"Fujitsuka","year":"2019","journal-title":"Mol. Genet. Metab. Rep."},{"key":"10.1016\/j.omtn.2024.102211_bib55","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.ymgme.2015.09.011","article-title":"Hematopoietic stem cell transplantation for Morquio A syndrome","volume":"117","author":"Yabe","year":"2016","journal-title":"Mol. Genet. Metabol."},{"key":"10.1016\/j.omtn.2024.102211_bib56","doi-asserted-by":"crossref","first-page":"4016","DOI":"10.1073\/pnas.071389098","article-title":"Dwarfism and early death in mice lacking C-type natriuretic peptide","volume":"98","author":"Chusho","year":"2001","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.omtn.2024.102211_bib57","doi-asserted-by":"crossref","first-page":"E1339","DOI":"10.1152\/ajpendo.00272.2009","article-title":"Chronically elevated plasma C-type natriuretic peptide level stimulates skeletal growth in transgenic mice","volume":"297","author":"Kake","year":"2009","journal-title":"Am. J. Physiol. Endocrinol. Metab."},{"key":"10.1016\/j.omtn.2024.102211_bib58","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1007\/s007740200048","article-title":"Significance of C-type natriuretic peptide (CNP) in endochondral ossification: analysis of CNP knockout mice","volume":"20","author":"Komatsu","year":"2002","journal-title":"J.\u00a0Bone Miner. Metabol."},{"key":"10.1016\/j.omtn.2024.102211_bib59","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1016\/j.bbrc.2008.08.139","article-title":"Hypomorphic mutation in mouse Nppc gene causes retarded bone growth due to impaired endochondral ossification","volume":"376","author":"Tsuji","year":"2008","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.omtn.2024.102211_bib60","doi-asserted-by":"crossref","first-page":"5916","DOI":"10.3390\/ijms23115916","article-title":"Molecular Mechanism of Induction of Bone Growth by the C-Type Natriuretic Peptide","volume":"23","author":"Rintz","year":"2022","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.omtn.2024.102211_bib61","doi-asserted-by":"crossref","first-page":"8547","DOI":"10.1038\/s41598-019-44975-w","article-title":"Exogenous C-type natriuretic peptide therapy for impaired skeletal growth in a murine model of glucocorticoid treatment","volume":"9","author":"Ueda","year":"2019","journal-title":"Sci. Rep."},{"key":"10.1016\/j.omtn.2024.102211_bib62","doi-asserted-by":"crossref","DOI":"10.1038\/srep10554","article-title":"The Local CNP\/GC-B system in growth plate is responsible for physiological endochondral bone growth","volume":"5","author":"Nakao","year":"2015","journal-title":"Sci. Rep."},{"key":"10.1016\/j.omtn.2024.102211_bib63","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1002\/art.38199","article-title":"Protective effects of C-type natriuretic peptide on linear growth and articular cartilage integrity in a mouse model of inflammatory arthritis","volume":"66","author":"B\u00fck\u00fclmez","year":"2014","journal-title":"Arthritis Rheumatol."},{"key":"10.1016\/j.omtn.2024.102211_bib64","doi-asserted-by":"crossref","first-page":"1108","DOI":"10.1016\/j.ajhg.2012.10.014","article-title":"Evaluation of the therapeutic potential of a CNP analog in a Fgfr3 mouse model recapitulating achondroplasia","volume":"91","author":"Lorget","year":"2012","journal-title":"Am. J. Hum. Genet."},{"key":"10.1016\/j.omtn.2024.102211_bib65","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.coviro.2016.08.001","article-title":"Cellular transduction mechanisms of adeno-associated viral vectors","volume":"21","author":"Berry","year":"2016","journal-title":"Curr. Opin. Virol."},{"key":"10.1016\/j.omtn.2024.102211_bib66","doi-asserted-by":"crossref","first-page":"25847","DOI":"10.1074\/jbc.M301223200","article-title":"Furin-mediated processing of Pro-C-type natriuretic peptide","volume":"278","author":"Wu","year":"2003","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.omtn.2024.102211_bib67","doi-asserted-by":"crossref","DOI":"10.1016\/j.peptides.2020.170363","article-title":"Circulating products of C-type natriuretic peptide and links with organ function in health and disease","volume":"132","author":"Prickett","year":"2020","journal-title":"Peptides"},{"key":"10.1016\/j.omtn.2024.102211_bib68","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0100637","article-title":"Expression of multiple transgenes from a single construct using viral 2A peptides in Drosophila","volume":"9","author":"Daniels","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.omtn.2024.102211_bib69","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1203\/01.PDR.0000113767.60140.E9","article-title":"Development and testing of new screening method for keratan sulfate in mucopolysaccharidosis IVA","volume":"55","author":"Tomatsu","year":"2004","journal-title":"Pediatr. Res."},{"key":"10.1016\/j.omtn.2024.102211_bib70","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.ymgme.2018.04.011","article-title":"Glycosaminoglycans analysis in blood and urine of patients with mucopolysaccharidosis","volume":"125","author":"Khan","year":"2018","journal-title":"Mol. Genet. Metabol."},{"key":"10.1016\/j.omtn.2024.102211_bib71","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1007\/s10545-014-9715-6","article-title":"Efficacy and safety of enzyme replacement therapy with BMN 110 (elosulfase alfa) for Morquio A syndrome (mucopolysaccharidosis IVA): a phase 3 randomised placebo-controlled study","volume":"37","author":"Hendriksz","year":"2014","journal-title":"J.\u00a0Inherit. Metab. Dis."},{"key":"10.1016\/j.omtn.2024.102211_bib72","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.ymgme.2016.05.018","article-title":"Long-term endurance and safety of elosulfase alfa enzyme replacement therapy in patients with Morquio A syndrome","volume":"119","author":"Hendriksz","year":"2016","journal-title":"Mol. Genet. Metabol."},{"key":"10.1016\/j.omtn.2024.102211_bib73","doi-asserted-by":"crossref","first-page":"S35","DOI":"10.1007\/s10545-009-9013-x","article-title":"Validation of keratan sulfate level in mucopolysaccharidosis type IVA by liquid chromatography-tandem mass spectrometry","volume":"33","author":"Tomatsu","year":"2010","journal-title":"J.\u00a0Inherit. Metab. Dis."},{"key":"10.1016\/j.omtn.2024.102211_bib74","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1016\/j.cell.2007.11.019","article-title":"Induction of pluripotent stem cells from adult human fibroblasts by defined factors","volume":"131","author":"Takahashi","year":"2007","journal-title":"Cell"},{"key":"10.1016\/j.omtn.2024.102211_bib75","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1038\/nbt957","article-title":"Correction of multi-gene deficiency in\u00a0vivo using a single 'self-cleaving' 2A peptide-based retroviral vector","volume":"22","author":"Szymczak","year":"2004","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.omtn.2024.102211_bib76","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1002\/dvg.22947","article-title":"Generation of an inducible fibroblast cell line for studying direct cardiac reprogramming","volume":"54","author":"Vaseghi","year":"2016","journal-title":"Genesis"},{"key":"10.1016\/j.omtn.2024.102211_bib77","doi-asserted-by":"crossref","first-page":"8621","DOI":"10.1523\/JNEUROSCI.0359-09.2009","article-title":"Faithful expression of multiple proteins via 2A-peptide self-processing: a versatile and reliable method for manipulating brain circuits","volume":"29","author":"Tang","year":"2009","journal-title":"J.\u00a0Neurosci."},{"key":"10.1016\/j.omtn.2024.102211_bib78","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0020553","article-title":"Bicistronic lentiviruses containing a viral 2A cleavage sequence reliably co-express two proteins and restore vision to an animal model of LCA1","volume":"6","author":"Verrier","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.omtn.2024.102211_bib79","doi-asserted-by":"crossref","first-page":"1643","DOI":"10.1039\/C4CC08502G","article-title":"Compact multi-enzyme pathways in P. pastoris","volume":"51","author":"Geier","year":"2015","journal-title":"Chem. Commun."},{"key":"10.1016\/j.omtn.2024.102211_bib80","doi-asserted-by":"crossref","first-page":"2193","DOI":"10.1038\/s41598-017-02460-2","article-title":"Systematic comparison of 2A peptides for cloning multi-genes in a polycistronic vector","volume":"7","author":"Liu","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.omtn.2024.102211_bib81","doi-asserted-by":"crossref","first-page":"5030","DOI":"10.1210\/en.2007-0695","article-title":"C-type natriuretic peptide regulates cellular condensation and glycosaminoglycan synthesis during chondrogenesis","volume":"148","author":"Woods","year":"2007","journal-title":"Endocrinology"},{"key":"10.1016\/j.omtn.2024.102211_bib82","doi-asserted-by":"crossref","DOI":"10.1210\/endocr\/bqaa008","article-title":"C-Type Natriuretic Peptide Restores Growth Impairment Under Enzyme Replacement in Mice With Mucopolysaccharidosis VII","volume":"161","author":"Yamashita","year":"2020","journal-title":"Endocrinology"},{"key":"10.1016\/j.omtn.2024.102211_bib83","doi-asserted-by":"crossref","first-page":"37","DOI":"10.5493\/wjem.v6.i2.37","article-title":"MicroRNA-regulated viral vectors for gene therapy","volume":"6","author":"Geisler","year":"2016","journal-title":"World J. Exp. Med."},{"key":"10.1016\/j.omtn.2024.102211_bib84","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1038\/gt.2010.157","article-title":"Liver-specific microRNA-122 target sequences incorporated in AAV vectors efficiently inhibits transgene expression in the liver","volume":"18","author":"Qiao","year":"2011","journal-title":"Gene Ther."},{"key":"10.1016\/j.omtn.2024.102211_bib85","doi-asserted-by":"crossref","first-page":"1288","DOI":"10.1172\/JCI125607","article-title":"Oral immunotherapy tolerizes mice to enzyme replacement therapy for Morquio A syndrome","volume":"130","author":"Sosa","year":"2020","journal-title":"J.\u00a0Clin. Invest."}],"container-title":["Molecular Therapy - Nucleic Acids"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2162253124000982?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2162253124000982?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,11,18]],"date-time":"2024-11-18T01:15:38Z","timestamp":1731892538000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2162253124000982"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,6]]},"references-count":85,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2024,6]]}},"alternative-id":["S2162253124000982"],"URL":"https:\/\/doi.org\/10.1016\/j.omtn.2024.102211","relation":{},"ISSN":["2162-2531"],"issn-type":[{"value":"2162-2531","type":"print"}],"subject":[],"published":{"date-parts":[[2024,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Adeno-associated virus-based gene therapy delivering combinations of two growth-associated genes to MPS IVA mice","name":"articletitle","label":"Article Title"},{"value":"Molecular Therapy - Nucleic Acids","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.omtn.2024.102211","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Author(s).","name":"copyright","label":"Copyright"}],"article-number":"102211"}}